Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The threat from the pink corner.

David M Livermore1

  • 1Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency, Central Public Health Laboratory, 61 Colindale Avenue, London NW9 5HT, UK. david.livermore@hpa.org.uk

Annals of Medicine
|July 9, 2003
PubMed
Summary

While methicillin-resistant Staphylococcus aureus (MRSA) presents current challenges, the slow rise of pan-resistant gram-negative pathogens like Pseudomonas aeruginosa is a more significant future threat. These bacteria exhibit broad resistance, complicating treatment for vulnerable patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine says go, doctor says no: an ecological momentary assessment analysis examining clinicians' perceptions of, and their antibiotic prescribing behaviour when using rapid molecular diagnostic tests in intensive care.

Antimicrobial resistance and infection control·2026
Same author

Cefalexin use in UK acute pyelonephritis practice: unaddressed challenges in dosing, breakpoints and clinical evidence.

The Journal of antimicrobial chemotherapy·2026
Same author

Assessing antimicrobial susceptibility testing guideline adherence by laboratories providing bacteriology services in Ghana: a pilot study.

The Journal of antimicrobial chemotherapy·2026
Same author

Importance of reviewing the package insert from gradient strip manufacturers.

The Journal of antimicrobial chemotherapy·2025
Same author

Rifampicin as monotherapy for infections caused by Staphylococcus aureus: considerations for not applying 'breakpoints in brackets'.

The Journal of antimicrobial chemotherapy·2025
Same author

The British Society for Antimicrobial Chemotherapy Resistance Surveillance Project: methods and limitations.

The Journal of antimicrobial chemotherapy·2025

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Gram-positive pathogens, such as methicillin-resistant Staphylococcus aureus (MRSA), are currently the primary focus of antibiotic resistance concerns.
  • However, the increasing prevalence of pan-resistant gram-negative pathogens poses a potentially greater, yet under-recognized, threat.

Purpose of the Study:

  • To highlight the escalating danger of pan-resistant gram-negative bacteria.
  • To contrast the current focus on MRSA with the more comprehensive resistance of emerging gram-negative strains.
  • To underscore the critical lack of new antibiotic development targeting gram-negative pathogens.

Main Methods:

  • Comparative analysis of antibiotic resistance profiles between gram-positive and gram-negative pathogens.

Related Experiment Videos

  • Review of clinical treatment challenges posed by pan-resistant gram-negative bacteria.
  • Assessment of the current antibiotic development pipeline for gram-negative infections.

    • Main Results:

    • Pan-resistant gram-negative bacteria, notably Pseudomonas aeruginosa and Acinetobacter baumannii, demonstrate broader antibiotic resistance than any gram-positive pathogen.
    • These resistant gram-negative strains are already causing treatment difficulties in immunocompromised patients, particularly in intensive care and specialized units.
    • There is a severe deficit in the development of novel antibiotics effective against these challenging gram-negative pathogens.

    Conclusions:

    • The emergence of pan-resistant gram-negative bacteria represents a critical and growing threat in healthcare settings.
    • The current focus on MRSA may be overshadowing the more profound danger posed by highly resistant gram-negative infections.
    • Urgent development of new antimicrobial agents targeting gram-negative pathogens is essential to avert a future public health crisis.